Why are blood transfusions from first-degree relatives (1st degree relatives) avoided in patients with aplastic anemia (bone marrow failure) and is irradiated blood product recommended for all or selective aplastic anemia patients?

Blood Transfusion Management in Aplastic Anemia

Why Avoid Transfusions from First-Degree Relatives

Blood transfusions from first-degree relatives (parents, siblings, children) must be avoided in aplastic anemia patients who are potential candidates for bone marrow transplantation because prior transfusion from a prospective donor significantly increases the risk of graft rejection. 1, 2

Mechanism of Sensitization

• Transfusion from a potential marrow donor sensitizes the recipient's immune system to donor antigens, leading to increased graft rejection rates 1, 2
• Even in multiply transfused patients, HLA-identical marrow transplantation survival is only 60-70%, compared to approximately 80% in untransfused patients 1
• Patients less than 18 years old who are untransfused or minimally transfused have greater than 90% survival with transplantation 1
• The risk of graft rejection is substantial enough that 12 of 49 patients in one series died from infection following marrow graft rejection 2

Clinical Impact

• Graft rejection was a major cause of transplant failure in early aplastic anemia series, accounting for significant mortality 2
• Patients diagnosed with aplastic anemia should have rapid HLA typing performed to identify possible marrow donors, and transfusions from prospective marrow donors should be strictly avoided 1

---

Irradiated Blood Products: Universal Requirement in Aplastic Anemia

All aplastic anemia patients require irradiated blood products, not just selective cases, due to the universal risk of transfusion-associated graft-versus-host disease (TA-GVHD) in this immunocompromised population. 3, 4, 5

Rationale for Universal Irradiation

• TA-GVHD is a rare but usually fatal complication with mortality exceeding 90% 5, 6
• Aplastic anemia patients have severe immunosuppression from their underlying bone marrow failure, placing them at high risk 4, 5
• The syndrome manifests with fever, maculopapular skin rash, desquamation, severe diarrhea, hepatitis, and pancytopenia from bone marrow hypoplasia 5

Mechanism of TA-GVHD Prevention

• Viable donor lymphocytes in blood products can mount an immune attack against the recipient's tissues 4
• Gamma irradiation with a minimum dose of 25 Gy is required to completely inactivate T lymphocytes and prevent cell division 3, 4, 5
• Leukocyte depletion alone is insufficient to prevent TA-GVHD; gamma irradiation is mandatory 3, 4, 5

Which Blood Products Require Irradiation

• All cellular blood components must be irradiated: red blood cells, platelets, granulocytes, and whole blood 4, 5
• Fresh frozen plasma and cryoprecipitate do not require irradiation as they contain no viable lymphocytes 5

Duration of Irradiation Requirement

• For aplastic anemia patients being considered for bone marrow transplantation, irradiated products should be used from diagnosis through the transplant period 4, 1
• If the patient proceeds to allogeneic transplant, continue irradiated products from conditioning until at least 6 months post-transplant (longer if chronic GVHD develops) 4

Additional High-Risk Scenarios in Aplastic Anemia

• Any transfusion from blood-related family members (not just first-degree relatives) carries particularly high risk due to HLA similarity facilitating lymphocyte engraftment 5, 6, 7
• The risk extends to grandparents, grandchildren, and blood-related aunts, uncles, nieces, and nephews due to shared HLA haplotypes 7
• Patients receiving immunosuppressive therapy with antithymocyte globulin (ATG) require irradiated products 3, 4

---

Critical Implementation Points

Common Pitfalls to Avoid

• Never assume leukoreduction is sufficient—it does not prevent TA-GVHD 3, 4, 5
• Communicate clearly with blood banks about the requirement for irradiated products, as approximately 30% of centers fail to irradiate for consensus indications 4
• Smaller centers without irradiators must arrange transfer to regional centers, which can cause delays; plan ahead 4
• Do not use blood from any blood-related family members without irradiation, even distant relatives 7

Practical Considerations

• Some centers irradiate all blood products for all patients to ensure vulnerable recipients receive proper products 3, 4
• Red blood cell units cannot be stored for long periods after irradiation due to membrane damage and potassium elevation 5
• Irradiation does not prevent alloimmunization or other transfusion reactions 5